Article Data

  • Views 551
  • Dowloads 114

Original Research

Open Access

The knowledge of risk factors and prevention of breast cancer in Polish women

  • K. Chmaj-Wierzchowska1,*,
  • M.U. Jurczyk1
  • B. Czech-Szczapa2
  • M. Wilczak3

1Department of Maternal and Child Health, University of Medical Sciences, Poznań, Poland

2Preventive Medicine Department, Poznań University of Medical Sciences, Poznań, Poland

3Department of Medical Education, University of Medical Sciences, Poznań, Poland

DOI: 10.12892/ejgo3566.2017 Vol.38,Issue 3,June 2017 pp.387-390

Published: 10 June 2017

*Corresponding Author(s): K. Chmaj-Wierzchowska E-mail: karolinachmaj@poczta.onet.pl

Abstract

Purpose: Currently, breast cancer is one of the most common malignancies among women and it constitutes a significant medical, economic, and social problem. Materials and Methods: The study was conducted in a group of 600 healthy women (aged 18 to 88 years) between September 2011 and February 2015 living in the region of Wielkopolska (Poland) in a private gynecological practice. A survey questionnaire designed specifically for purposes of the study was a tool used to conduct the study. Results: With regards to risk factors for breast cancer: 93% - familial history of breast cancer, 46% - use of hormone treatment, and 40.16% - taking contraceptive pills. Conclusions: A significant component of breast cancer prevention should be providing information regarding prevention tests and increasing accessibility to medical services.

Keywords

isk factors; Prevention; Breast cancer; Predisposing factors; Familial history; Hormone treatment; Contraceptive pills.

Cite and Share

K. Chmaj-Wierzchowska,M.U. Jurczyk,B. Czech-Szczapa,M. Wilczak. The knowledge of risk factors and prevention of breast cancer in Polish women. European Journal of Gynaecological Oncology. 2017. 38(3);387-390.

References

[1] Leźnicka M., Mierzwa T., Jachimowicz–Wołoszynek D., Żyrkowski J.: “The individual invitation system vs. women’s attendance rate at preventive tests performed as a part of oncological prevention programs”. Probl. Hig. Epidemiol., 2009, 90, 627.

[2] Tkaczuk-Włach J., Sobstyl M., Jakiel G.: “Rak piersi – znaczenie profilaktyki pierwotnej i wtórnej”. Menopause Rev., 2012, 4, 343. [Article in Polish]

[3] El Saghir N.S., Anderson B.O.: “Breast cancer early detection and resources: Where in the world do we start?” Breast, 2012, 21, 423.

[4] Połać I., Wilamowska A., Stetkiewicz T., Pertyński T.: “Dense breast – a breast cancer risk factor”. Menopause Rev., 2008, 7, 273. [Article in Polish]

[5] Malicka I., Pawłowska K.: “Physical activity in primary and secondary prevention of breast cancer”. Rehabil Med., 2008, 12, 24. [Article in Polish]

[6] Stasiołek D., Kwaśniewska M., Drygas W.: “Breast cancer: selected risk factors, primary prevention”. Prz Lek., 2002, 59, 26. [Article in Polish]

[7] Horner M.J., Ries L.A.G., Krapcho M., Neyman N., Aminou R., Howlader N., et al.: “SEER cancer Statistics Review, 1975-2006, National Cancer Institute”. Bethesda, MD: National Cancer Institute; 2009 Available at: http://seer.cancer.gov/archive/csr/1975_2006/index.html

[8] Wypych A., Zejda J.E.: “Modes of detection of breast cancer and their diagnostic relevance in urban area of Katowice, Poland”. Probl. Hig. Epidemiol., 2006, 87, 108. [Article in Polish]

[9] Pacian A., Ferenc W., Jędrasik M.: “Young women’s awareness of breast cancer prevention”. Palliative Medicine, 2014, 6, 151. [Article in Polish]

[10] Krzywonos A., Ochałek K., Krzywonos-Zawadzka A., Pitala A.: “Assessment of knowledge of cancer and lymphoedema among breast cancer survivors”. Menopause Rev., 2014, 13, 273.

[11] Narod S.A.: “Hormonal prevention of hereditary breast cancer”. Ann. N. Y. Acad. Sci., 2001, 952, 36.

[12] Marchbanks P.A., Curtis K.M., Mandel M.G., Wilson H.G., Jeng G., Folger S.G., et al.: “Oral contraceptive formulation and risk of breast cancer”. Contraception, 2012, 85, 342.

[13] Grabrick D.M., Hartmann L.C., Cerhan J.R., Vierkant R.A., Therneau T.M., Vachon C.M., et al.: “Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer”. JAMA, 2000, 284, 1791.

[14] Muszyńska A., Mastalerz-Migas A., Brona A.: “Stan wiedzy polskich kobiet na temat profilaktyki raka piersi”. Fam. Med. Prim. Care, Rev., 2006, 8, 708. [Article in Polish]

[15] Humphrey L.L., Helfand M., Chan B.K., Woolf S.H.: “Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force”. Ann. Intern. Med., 2002, 137, 347.

[16] US Preventive Services Task Force: “Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement”. Ann. Intern. Med., 2009, 151, 716.

[17] Didkowska J.: “Wskaźniki zdrowotne chorób nowotworowych w Polsce na tle Europy. Onkologia w praktyce klinicznej”. Wydanie specjalne, 2010, 24.

[18] Tavafian S.S., Hasani L., Aghamolaei T., Zare S., Gregory D.: “Prediction of breast self-examination in a sample of Iranian women: an application of the Health Belief Model”. BMC Womens Health, 2009, 9, 37.

[19] Naghibi S.A., Shojaizadeh D., Montazeri A., Yazdani Cherati J.: “Sociocultural factors associated with breast self-examination among Iranian women”. Acta Med. Iran, 2015, 53, 62.

[20] World Health Organization: “Breast cancer: prevention and control”. Geneva: World Health Organization, 2009. Available at: www.who.int/cancer/detection/ breastcancer/en/index.html

[21] Jurczyk M., Werfel A., Pisarska-Krawczyk M.: “Brachytherapy used in tretment of the breast cancer”. Ginek. Prakt., 2009, 17, 3.

[22] Hammer J., Jurczyk M., Pisarska M., Track Ch., Stanek J., Grodecka-Gazdecka S., et al.: “Interstitial high dose rate 192-Iridium boost in breast cancer treatment”. Prz Ginek. Położ., 2004, 4, 107.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top